Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Lotze

Showing results (181-190 of 242) with videos related to

Pageof 25
Sort By:
Gene Therapy|August 6, 1999
Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccineH Okada, K M Giezeman-Smits, H Tahara, et al.
Annals of Surgical Oncology|July 1, 1995
Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trialJ T Rubin, M T Lotze, D Rosenfelder, et al.
Surgery|August 1, 1986
A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2S A Rosenberg, M T Lotze, L M Muul, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1989
In vitro complex formation and biodistribution of mouse antitumor monoclonal antibody in cancer patientsH Sakahara, J C Reynolds, J A Carrasquillo, et al.
European Journal of Immunology|March 1, 1994
Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assayG Stuber, G H Leder, W T Storkus, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in manA Kasid, S Morecki, P Aebersold, et al.
Oncology|March 13, 2001
Phase II trial of systemic recombinant interleukin-2 in the treatment of refractory nasopharyngeal carcinomaK H Chi, J N Myers, K C Chow, et al.
Cancer Gene Therapy|February 24, 2001
Potent antitumor effects of intra-arterial injection of fibroblasts genetically engineered to express IL-12 in liver metastasis model of rat: no additional benefit of using retroviral producer cellT Iwazawa, G Y Chau, T Mori, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2M T Lotze, Y L Matory, S E Ettinghausen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humansD M Jablons, J J Mulé, J K McIntosh, et al.
Pageof 25

Showing results (181-190 of 242) with videos related to

Sort By:
Pageof 25
Gene Therapy|August 6, 1999
Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccineH Okada, K M Giezeman-Smits, H Tahara, et al.
Annals of Surgical Oncology|July 1, 1995
Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trialJ T Rubin, M T Lotze, D Rosenfelder, et al.
Surgery|August 1, 1986
A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2S A Rosenberg, M T Lotze, L M Muul, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1989
In vitro complex formation and biodistribution of mouse antitumor monoclonal antibody in cancer patientsH Sakahara, J C Reynolds, J A Carrasquillo, et al.
European Journal of Immunology|March 1, 1994
Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assayG Stuber, G H Leder, W T Storkus, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in manA Kasid, S Morecki, P Aebersold, et al.
Oncology|March 13, 2001
Phase II trial of systemic recombinant interleukin-2 in the treatment of refractory nasopharyngeal carcinomaK H Chi, J N Myers, K C Chow, et al.
Cancer Gene Therapy|February 24, 2001
Potent antitumor effects of intra-arterial injection of fibroblasts genetically engineered to express IL-12 in liver metastasis model of rat: no additional benefit of using retroviral producer cellT Iwazawa, G Y Chau, T Mori, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2M T Lotze, Y L Matory, S E Ettinghausen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humansD M Jablons, J J Mulé, J K McIntosh, et al.
Pageof 25